核酸検査市場：適応症別、製品別、手法別、エンドユーザー別-2025-2030年の世界予測

核酸検査市場は、2023年に34億3,000万米ドルと評価され、2024年には37億9,000万米ドルに達すると予測され、CAGR 10.30％で成長し、2030年には68億3,000万米ドルになると予測されています。

核酸検査（NAT）は、DNAやRNAのような遺伝物質を検出・増幅し、病原体や異常を特定する機能を備えた分子診断薬市場の中でも重要なセグメントです。その必要性は、特にCOVID-19のパンデミックや感染症の増加といった世界の健康課題に照らして、正確な診断ツールに対する需要が高まっていることに起因しています。NATの応用分野は血液スクリーニング、感染症診断、腫瘍学など多岐にわたり、ヘルスケア環境、研究機関、バイオテクノロジー企業にサービスを提供しています。主な成長要因としては、増幅法の技術的進歩、ヘルスケア支出の増加、病気の早期発見に対する意識の高まりなどが挙げられます。さらに、遺伝子やゲノムデータに後押しされた医療の個別化により、精密治療の機会が広がっています。しかし市場は、検査コストの高さ、規制上のハードル、専門的な検査インフラが必要といった課題に直面しており、特に低開発地域における普及を妨げる可能性があります。とはいえ、ポイント・オブ・ケア検査の革新と侵襲性の低いサンプル採取法の開発には、ユーザーフレンドリーで迅速な検査ソリューションを促進するエキサイティングな機会が潜んでいます。AIや機械学習とNATの統合は、データ解釈に革命をもたらし、診断精度とスループットを向上させる可能性もあります。事業成長のためには、企業は研究開発の機が熟している分野である、複雑な研究室環境への依存を軽減するポータブルで費用対効果の高いキットの開発に注力すべきです。特定のニーズを理解するためのヘルスケアプロバイダーとの協力や、新興市場への進出のためのパートナーシップは、競争力を高めることができます。市場が徐々に分散型検査環境へと移行する中、スケーラブルで標準化されたソリューションを提供する能力が極めて重要になります。一歩先を行くには、規制状況への継続的な対応と、進化する技術環境への機敏な適応が必要であり、特にモバイルヘルスアプリケーションの新たな可能性が注目されます。

市場力学：急速に進化する核酸検査市場の主要市場インサイトを公開

核酸検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • がんやその他の感染症患者の増加
  • ヒト遺伝子検査の商業化の増加
  • パンデミック対策と撲滅におけるニーズの急増
• 市場抑制要因
  • 莫大な研究開発費
• 市場機会
  • 検査能力を拡大するための魅力的な資金調達の場と政府支援
  • 政府による承認と償還の増加
• 市場の課題
  • 複雑な装置と技術

ポーターの5つの力：核酸検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：核酸検査市場における外部からの影響の把握

外部マクロ環境要因は、核酸検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析核酸検査市場における競合情勢の把握

核酸検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス核酸検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、核酸検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨核酸検査市場における成功への道筋を描く

核酸検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がんやその他の感染症の増加
    • ヒト遺伝子検査の商業化の増加
    • パンデミックの制御と根絶の急激な必要性
  • 抑制要因
    • 研究開発費の巨額支出
  • 機会
    • 検査能力を拡大するための魅力的な資金スペースと政府の支援
    • 政府の承認と払い戻しの増加
  • 課題
    • 複雑な計測機器と技術
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 核酸検査市場適応症別

• がん
• 法医学検査
• 遺伝性疾患およびミトコンドリア疾患
• 感染症

第7章 核酸検査市場：製品別

• 消耗品
• 核酸検査キット

第8章 核酸検査市場：技術別

• プローブ増幅システム
• 信号増幅
• ターゲット増幅システム

第9章 核酸検査市場：エンドユーザー別

• 病院
• 病理学研究室
• 調査機関

第10章 南北アメリカの核酸検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の核酸検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの核酸検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 23andMe, Inc.
• Abbott Laboratories
• Agilent Technologies, Inc.
• ARUP Laboratories
• Asuragen Inc.
• Beckman Coulter, Inc.
• Becton Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Biomerieux SA
• Cepheid
• F. Hoffmann-La Roche Ltd.
• Gen-Probe, Inc.
• Illumina, Inc.
• Novartis AG
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. NUCLEIC ACID TESTING MARKET RESEARCH PROCESS
• FIGURE 2. NUCLEIC ACID TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. NUCLEIC ACID TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. NUCLEIC ACID TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NUCLEIC ACID TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NUCLEIC ACID TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY GENETIC & MITOCHONDRIAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY NUCLEIC ACID TEST KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PROBE AMPLIFICATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SIGNAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TARGET AMPLIFICATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PATHOLOGY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 37. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 132. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 148. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 152. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. NUCLEIC ACID TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 192. NUCLEIC ACID TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Nucleic Acid Testing Market was valued at USD 3.43 billion in 2023, expected to reach USD 3.79 billion in 2024, and is projected to grow at a CAGR of 10.30%, to USD 6.83 billion by 2030.

Nucleic Acid Testing (NAT) represents a significant segment within the molecular diagnostics market, equipped to detect and amplify genetic material like DNA and RNA to identify pathogens or anomalies. Its necessity stems from the growing demand for accurate diagnostic tools, especially in light of global health challenges such as the COVID-19 pandemic and rising incidences of infectious diseases. NAT's applications span across diverse segments including blood screening, infectious disease diagnosis, and oncology, serving healthcare settings, research institutions, and biotechnology firms. Key growth factors include technological advancements in amplification methods, increased healthcare expenditures, and heightened awareness of early disease detection. Moreover, personalization in medicine, driven by genetic and genomic data, opens opportunities in precision therapies. However, the market faces challenges such as high test costs, regulatory hurdles, and the requirement for specialized laboratory infrastructure, which could hamper widespread adoption, especially in underdeveloped regions. Nevertheless, exciting opportunities lie in point-of-care testing innovations and the development of less invasive sample collection methods, fostering user-friendly and rapid testing solutions. The integration of AI and machine learning with NAT could also revolutionize data interpretation, enhancing diagnostic accuracy and throughput. For business growth, companies should focus on developing portable, cost-effective nucleic acid testing kits that reduce dependency on complex lab settings, an area ripe for research and development. Collaborations with healthcare providers to understand specific needs and partnerships for expanding into emerging markets can provide a competitive edge. As the market gradually transitions towards decentralized testing environments, the ability to offer scalable and standardized solutions will be crucial. To stay ahead, continuous focus on regulatory compliance and agile adaptation to evolving technological landscapes will be necessary, especially concerning emerging potential for mobile health applications.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nucleic Acid Testing Market

The Nucleic Acid Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising cases of cancer and other infectious diseases
  • Increased commercialization of human genetic tests
  • Exponential need in pandemic control and eradication
• Market Restraints
  • Huge expenditure on R&D
• Market Opportunities
  • Attractive funding space and government support to expand testing capabilities
  • Increasing government approvals and reimbursements available
• Market Challenges
  • Complex instrumentation and technology

Porter's Five Forces: A Strategic Tool for Navigating the Nucleic Acid Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nucleic Acid Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nucleic Acid Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nucleic Acid Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nucleic Acid Testing Market

A detailed market share analysis in the Nucleic Acid Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nucleic Acid Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nucleic Acid Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nucleic Acid Testing Market

A strategic analysis of the Nucleic Acid Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nucleic Acid Testing Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Abbott Laboratories, Agilent Technologies, Inc., ARUP Laboratories, Asuragen Inc., Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerieux SA, Cepheid, F. Hoffmann-La Roche Ltd., Gen-Probe, Inc., Illumina, Inc., Novartis AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Nucleic Acid Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Indication, market is studied across Cancer, Forensic Testing, Genetic & Mitochondrial Disorders, and Infectious Disease.
• Based on Product, market is studied across Consumables and Nucleic Acid Test Kits.
• Based on Technique, market is studied across Probe Amplification Systems, Signal Amplification, and Target Amplification Systems.
• Based on End User, market is studied across Hospitals, Pathology Laboratories, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising cases of cancer and other infectious diseases
    • 5.1.1.2. Increased commercialization of human genetic tests
    • 5.1.1.3. Exponential need in pandemic control and eradication
  • 5.1.2. Restraints
    • 5.1.2.1. Huge expenditure on R&D
  • 5.1.3. Opportunities
    • 5.1.3.1. Attractive funding space and government support to expand testing capabilities
    • 5.1.3.2. Increasing government approvals and reimbursements available
  • 5.1.4. Challenges
    • 5.1.4.1. Complex instrumentation and technology
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Nucleic Acid Testing Market, by Indication

• 6.1. Introduction
• 6.2. Cancer
• 6.3. Forensic Testing
• 6.4. Genetic & Mitochondrial Disorders
• 6.5. Infectious Disease

7. Nucleic Acid Testing Market, by Product

• 7.1. Introduction
• 7.2. Consumables
• 7.3. Nucleic Acid Test Kits

8. Nucleic Acid Testing Market, by Technique

• 8.1. Introduction
• 8.2. Probe Amplification Systems
• 8.3. Signal Amplification
• 8.4. Target Amplification Systems

9. Nucleic Acid Testing Market, by End User

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Pathology Laboratories
• 9.4. Research Institutes

10. Americas Nucleic Acid Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Nucleic Acid Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Nucleic Acid Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 23andMe, Inc.
• 2. Abbott Laboratories
• 3. Agilent Technologies, Inc.
• 4. ARUP Laboratories
• 5. Asuragen Inc.
• 6. Beckman Coulter, Inc.
• 7. Becton Dickinson and Company
• 8. Bio-Rad Laboratories, Inc.
• 9. Biomerieux SA
• 10. Cepheid
• 11. F. Hoffmann-La Roche Ltd.
• 12. Gen-Probe, Inc.
• 13. Illumina, Inc.
• 14. Novartis AG
• 15. Thermo Fisher Scientific Inc.